These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9749657)

  • 1. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
    Klabunde CN; Potosky AL; Harlan LC; Kramer BS
    Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.
    Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL
    J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002.
    Rose AJ; Backus BM; Gershman ST; Santos P; Ash AS; Battaglia TA
    Med Care; 2007 May; 45(5):440-7. PubMed ID: 17446830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.
    Zeliadt SB; Potosky AL; Etzioni R; Ramsey SD; Penson DF
    Urology; 2004 Dec; 64(6):1171-6. PubMed ID: 15596192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician visits prior to treatment for clinically localized prostate cancer.
    Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
    Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital racial composition and the treatment of localized prostate cancer.
    Pollack CE; Bekelman JE; Liao KJ; Armstrong K
    Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.
    Hamilton AS; Fleming ST; Wang D; Goodman M; Wu XC; Owen JB; Lo M; Ho A; Anderson RT; Thompson T
    Am J Clin Oncol; 2016 Feb; 39(1):55-63. PubMed ID: 24390274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic.
    Bernstein AN; Talwar R; Handorf E; Syed K; Danella J; Ginzburg S; Belkoff L; Reese AC; Tomaszewski J; Trabulsi E; Singer EA; Jacobs B; Kutikov A; Uzzo R; Raman JD; Guzzo T; Smaldone MC; Correa A
    JAMA Oncol; 2021 Oct; 7(10):1467-1473. PubMed ID: 34292311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding variation in primary prostate cancer treatment within the Veterans Health Administration.
    Nambudiri VE; Landrum MB; Lamont EB; McNeil BJ; Bozeman SR; Freedland SJ; Keating NL
    Urology; 2012 Mar; 79(3):537-45. PubMed ID: 22245306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States).
    Morris CR; Snipes KP; Schlag R; Wright WE
    Cancer Causes Control; 1999 Dec; 10(6):503-11. PubMed ID: 10616820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in use of imaging in a national sample of men with early-stage prostate cancer.
    Saigal CS; Pashos CL; Henning JM; Litwin MS
    Urology; 2002 Mar; 59(3):400-4. PubMed ID: 11880080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of prostate cancer treatment by clinical stage and age.
    Meltzer D; Egleston B; Abdalla I
    Am J Public Health; 2001 Jan; 91(1):126-8. PubMed ID: 11189804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States.
    Mahase SS; D'Angelo D; Kang J; Hu JC; Barbieri CE; Nagar H
    JAMA Netw Open; 2020 Feb; 3(2):e1920471. PubMed ID: 32022878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
    Harlan L; Brawley O; Pommerenke F; Wali P; Kramer B
    J Clin Oncol; 1995 Jan; 13(1):93-100. PubMed ID: 7799048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.
    Pollack CE; Bekelman JE; Epstein AJ; Liao K; Wong YN; Armstrong K
    Med Care; 2011 Nov; 49(11):999-1006. PubMed ID: 22005606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.